Frank I. Scott MD MSCE
Frank I. Scott, MD, MSCE, is an expert in inflammatory bowel disease and epidemiology at the Crohn’s and Colitis Center in the Division of Gastroenterology and Hepatology at the University of Colorado Anschutz Medical Campus. His research interests include maximizing the risk-benefit balance of biologic and immunosuppressive therapies in IBD, optimizing medication delivery in IBD, and exploring novel pharmacoepidemiologic association in IBD and other gastrointestinal disorders. His work has been funded by the National Institutes of Health, Crohn’s and Colitis Foundation, and several industry partners.
Dr. Scott reports having received research grants from the National Institutes of Health, Crohn’s and Colitis Foundation, Takeda Pharmaceuticals USA , and Janssen Pharmaceuticals, and having received consulting fees from PRIME Incorporated, Janssen Pharmaceuticals, Takeda Pharmaceuticals, and Merck Pharmaceuticals.